Last Price$34.91.0%
Market Cap$17.9B
LTM Operating Income margin
(1.1%)
5Y avg
8.1%
Medical - Instruments & Supplies industry
median
(4.8%)
Stock quality & Intrinsic value
5/10
0.5% undervalued
Baxter International Inc. Operating Income margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income margin | 16.6% | 17.7% | 19.2% | 20.8% | 22.9% | 16.6% | 21.2% | 19.9% | 17.5% | 15.4% | 4.5% | 7.1% | 12.2% | 14.4% | 8.6% | 5.2% | 6.1% | (3.6%) | 2.6% | (2.5%) |
Overvalued or undervalued?
Check the intrinsic value for BAX
and see if it's the right time to invest.
Baxter International Inc. (BAX) Operating Income margin comparison analysis
General
LTM Operating Income margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Baxter International Inc.BAX
(1.1%)
(69.5%)
(100.0%)
(6.9%)
Median Peer Set
16.2%
3.4%
23.0%
10.4%
ResMed Inc.RMD
31.7%
10.9%
13.4%
21.8%
Intuitive Surgical, Inc.ISRG
28.1%
17.2%
27.7%
27.8%
Hologic, Inc.HOLX
23.9%
(0.0%)
81.1%
19.6%
West Pharmaceutical Services, Inc.WST
19.9%
(1.9%)
(15.5%)
17.0%
The Cooper Companies, Inc.COO
18.1%
8.4%
32.2%
10.1%
Alcon Inc.ALC
14.2%
8.5%
182.9%
10.3%
AptarGroup, Inc.ATR
14.1%
2.7%
30.2%
10.5%
Becton, Dickinson and CompanyBDX
12.9%
4.2%
18.3%
8.4%
Repligen CorporationRGEN
(0.8%)
(21.1%)
(80.9%)
5.6%
Masimo CorporationMASI
(12.7%)
0.6%
(42.5%)
4.0%
BAX key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 9,849.0 3.6% | 10,378.0 5.4% | 11,263.0 8.5% | 12,348.0 9.6% | 12,562.0 1.7% | 12,843.0 2.2% | 13,893.0 8.2% | 14,190.0 2.1% | 15,259.0 7.5% | 16,671.0 9.3% | 9,968.0 (40.2%) | 10,163.0 2.0% | 10,561.0 3.9% | 11,127.0 5.4% | 11,362.0 2.1% | 11,673.0 2.7% | 12,784.0 9.5% | 15,113.0 18.2% | 14,813.0 (2.0%) | 4,513.0 (69.5%) |
| Cost of Goods Sold (COGS) | 5,756.0 | 5,641.0 | 5,744.0 | 6,218.0 | 6,037.0 | 6,885.0 | 6,847.0 | 6,889.0 | 7,664.0 | 8,514.0 | 5,822.0 | 6,053.0 | 6,091.0 | 6,346.0 | 6,601.0 | 7,086.0 | 7,679.0 | 9,716.0 | 9,838.0 | 2,812.0 |
% margin | 4,093.0 41.6% | 4,737.0 45.6% | 5,519.0 49.0% | 6,130.0 49.6% | 6,525.0 51.9% | 5,958.0 46.4% | 7,046.0 50.7% | 7,301.0 51.5% | 7,595.0 49.8% | 8,157.0 48.9% | 4,146.0 41.6% | 4,110.0 40.4% | 4,470.0 42.3% | 4,781.0 43.0% | 4,761.0 41.9% | 4,587.0 39.3% | 5,105.0 39.9% | 5,397.0 35.7% | 4,975.0 33.6% | 1,701.0 37.7% |
| Operating Expenses | 2,563.0 | 2,896.0 | 3,281.0 | 3,566.0 | 3,648.0 | 3,822.0 | 4,100.0 | 4,480.0 | 4,927.0 | 5,450.0 | 3,697.0 | 3,386.0 | 3,212.0 | 3,182.0 | 3,885.0 | 2,971.0 | 3,395.0 | 4,528.0 | 4,585.0 | 1,384.0 |
| Research & Development Expenses (R&D) | 533.0 | 614.0 | 760.0 | 868.0 | 917.0 | 915.0 | 946.0 | 1,156.0 | 1,246.0 | 1,421.0 | 603.0 | 647.0 | 613.0 | 655.0 | 595.0 | 521.0 | 534.0 | 605.0 | 667.0 | 181.0 |
| Selling, General & Administrative Expenses (SG&A) | 2,030.0 | 2,282.0 | 2,521.0 | 2,698.0 | 2,731.0 | 2,907.0 | 3,154.0 | 3,324.0 | 3,681.0 | 4,029.0 | 3,094.0 | 2,739.0 | 2,599.0 | 2,617.0 | 3,290.0 | 2,469.0 | 2,867.0 | 3,887.0 | 3,938.0 | 1,203.0 |
% margin | 1,639.0 16.6% | 1,841.0 17.7% | 2,168.0 19.2% | 2,564.0 20.8% | 2,877.0 22.9% | 2,136.0 16.6% | 2,946.0 21.2% | 2,821.0 19.9% | 2,668.0 17.5% | 2,562.0 15.4% | 449.0 4.5% | 724.0 7.1% | 1,291.0 12.2% | 1,599.0 14.4% | 976.0 8.6% | 603.0 5.2% | 779.0 6.1% | (549.0) (3.6%) | 390.0 2.6% | (112.0) (2.5%) |
| Interest Income | 0.0 | 0.0 | 102.0 | 72.0 | 19.0 | 28.0 | 38.0 | 26.0 | 27.0 | 22.0 | 20.0 | 23.0 | 30.0 | 48.0 | 40.0 | 19.0 | 14.0 | 20.0 | 70.0 | 0.0 |
| Interest Expense | 118.0 | 101.0 | 124.0 | 148.0 | 98.0 | 87.0 | 54.0 | 87.0 | 128.0 | 145.0 | 126.0 | 66.0 | 85.0 | 45.0 | 111.0 | 134.0 | 192.0 | 395.0 | 512.0 | 13.0 |
| Pre-tax Income | 1,444.0 | 1,746.0 | 2,114.0 | 2,451.0 | 2,734.0 | 1,890.0 | 2,809.0 | 2,889.0 | 2,549.0 | 2,439.0 | 428.0 | 4,954.0 | 1,217.0 | 1,693.0 | 970.0 | 1,292.0 | 1,477.0 | (2,353.0) | (103.0) | (135.0) |
% effective tax rate | 486.0 33.7% | 348.0 19.9% | 407.0 19.3% | 437.0 17.8% | 519.0 19.0% | 463.0 24.5% | 553.0 19.7% | 563.0 19.5% | 537.0 21.1% | 493.0 20.2% | 28.0 6.5% | (12.0) (0.2%) | 493.0 40.5% | 63.0 3.7% | (41.0) (4.2%) | 182.0 14.1% | 182.0 12.3% | 68.0 (2.9%) | (34.0) 33.0% | 177.0 (131.1%) |
% margin | 956.0 9.7% | 1,396.0 13.5% | 1,707.0 15.2% | 2,014.0 16.3% | 2,205.0 17.6% | 1,420.0 11.1% | 2,224.0 16.0% | 2,326.0 16.4% | 2,012.0 13.2% | 2,497.0 15.0% | 968.0 9.7% | 4,965.0 48.9% | 717.0 6.8% | 1,624.0 14.6% | 1,001.0 8.8% | 1,102.0 9.4% | 1,284.0 10.0% | (2,421.0) (16.0%) | 2,656.0 17.9% | (312.0) (6.9%) |
| EPS | 1.54 | 2.15 | 2.65 | 3.22 | 3.63 | 2.41 | 3.91 | 4.22 | 3.70 | 4.61 | 1.78 | 9.09 | 1.11 | 3.04 | 1.97 | 2.17 | 2.56 | (4.80) | 5.25 | 0.00 |
| Diluted EPS | 1.52 | 2.13 | 2.61 | 3.16 | 3.59 | 2.39 | 3.88 | 4.18 | 3.66 | 4.56 | 1.76 | 9.01 | 1.08 | 2.97 | 1.93 | 2.13 | 2.53 | (4.80) | 5.25 | 0.00 |
% margin | 2,190.0 22.2% | 2,416.0 23.3% | 2,819.0 25.0% | 3,230.0 26.2% | 3,406.0 27.1% | 2,767.0 21.5% | 3,633.0 26.1% | 3,697.0 26.1% | 3,488.0 22.9% | 1,636.0 9.8% | 1,494.0 15.0% | 1,972.0 19.4% | 2,050.0 19.4% | 2,477.0 22.3% | 1,870.0 16.5% | 2,536.0 21.7% | 2,519.0 19.7% | (849.0) (5.6%) | 1,678.0 11.3% | (112.0) (2.5%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Baxter International Inc.'s Operating Income margin?
As of today, Microsoft Corp's last 12-month Operating Income margin is (1.1%), based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Operating Income margin for Baxter International Inc. have been 5.4% over the past three years, and 8.5% over the past five years.
2) Is Baxter International Inc.'s Operating Income margin Good?
As of today, Baxter International Inc.'s Operating Income margin is (1.1%), which is higher than industry median of (4.8%). It indicates that Baxter International Inc.'s Operating Income margin is Good.